Article
In vitro evidence of synergistic efficacy with asciminib combined with reduced dose of ATP-binding pocket tyrosine kinase inhibitors according to the ABL1 kinase domain mutation profile.
Leukemia - 1 Feb 2024
Han Ho-Jae, Kim Jaeyoon John, Pyne Danielle, Travas Anthea, Ambalavanan Amirthagowri, Kimura Shinya, Deininger Michael W, Kim Jong-Won, Kim Dennis Dong Hwan
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.